“Theoretical Study of Angiotensin Receptor Blockers Losartan Candesartan and Olmesartan and Their Suggested Metabolites”, NTU-JPS, vol. 1, no. 2, pp. 39–47, May 2022, doi: 10.56286/ntujps.v1i2.217.